Max Sugarman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Max Sugarman has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Ana Jovanovic
Mark Holland Metabolic Unit Salford Royal NHS Foundation Trust Salford UK
2 shared publications- Anders Oldfors
Department of Laboratory Medicine, Institute of Biomedicine University of Gothenburg Gothenburg Sweden
1 shared publication - Andrew King
Department of Clinical Neuropathology, King’s College Hospital, Denmark Hill, London SE5 9RS, UK
1 shared publication Blair Graham
Nursing and Midwifery, University of Plymouth, Plymouth, UK
1 shared publication- Carola Hedberg-Oldfors
Department of Laboratory Medicine, Institute of Biomedicine University of Gothenburg Gothenburg Sweden
1 shared publication - David M. Lowe
University College London
1 shared publication
Latest Publications
- 13 January 2021
- Published by BMJ in Emergency Medicine Journal
- Vol. 38 (8) , 579-584
Implementation of the ‘TAKE STOCK’ Hot Debrief Tool in the ED: a quality improvement project
Hot debriefing (HoD) describes a structured team-based discussion which may be initiated following a significant event. Benefits may include improved teamwork, staff well-being and identification of learning opportunities. Existing literature indicates that while staff value HoD following significant events, it is infrequently undertaken in practice. Internationally, several frameworks for HoD have been developed, although none are widely adopted for use in the ED. A quality improvement project was conducted to introduce HoD into a single UK ED in North West England, between January and March 2019. Following stakeholder consultation, the 9-item ‘TAKE STOCK’ tool was developed. Implementation of the tool increased the number of HoD (0—2.2 HoD episodes/week). Findings from the first plan-do-study-act (PDSA) cycle are presented, which revealed the key strengths and limitations of this model. Staff perceptions of the tool were evaluated using a self-administered short questionnaire designed by the authors. Satisfaction with TAKE STOCK was assessed using 10-point numerical scales. Across respondents (n−15), average satisfaction scores exceeded 9 out of 10 concerning patient care, staff self-care, decision-making, education, teamwork and identification of equipment issues. Implementation of HoD into the ED is feasible and viewed as beneficial by staff. Implementation toolkits for TAKE STOCK have been requested by 42 additional UK hospitals and ambulance trusts, demonstrating significant interest in its use. Research is now required to formally validate HoD frameworks for use in the ED, and assess whether HoD results in sustained improvements to staff and patient outcomes.
- 13 January 2021
- Published by BMJ in Emergency Medicine Journal
- Vol. 38 (8) , 579-584
Implementation of the ‘TAKE STOCK’ Hot Debrief Tool in the ED: a quality improvement project
Hot debriefing (HoD) describes a structured team-based discussion which may be initiated following a significant event. Benefits may include improved teamwork, staff well-being and identification of learning opportunities. Existing literature indicates that while staff value HoD following significant events, it is infrequently undertaken in practice. Internationally, several frameworks for HoD have been developed, although none are widely adopted for use in the ED. A quality improvement project was conducted to introduce HoD into a single UK ED in North West England, between January and March 2019. Following stakeholder consultation, the 9-item ‘TAKE STOCK’ tool was developed. Implementation of the tool increased the number of HoD (0—2.2 HoD episodes/week). Findings from the first plan-do-study-act (PDSA) cycle are presented, which revealed the key strengths and limitations of this model. Staff perceptions of the tool were evaluated using a self-administered short questionnaire designed by the authors. Satisfaction with TAKE STOCK was assessed using 10-point numerical scales. Across respondents (n−15), average satisfaction scores exceeded 9 out of 10 concerning patient care, staff self-care, decision-making, education, teamwork and identification of equipment issues. Implementation of HoD into the ED is feasible and viewed as beneficial by staff. Implementation toolkits for TAKE STOCK have been requested by 42 additional UK hospitals and ambulance trusts, demonstrating significant interest in its use. Research is now required to formally validate HoD frameworks for use in the ED, and assess whether HoD results in sustained improvements to staff and patient outcomes.
- 18 March 2020
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 43 (5) , 1002-1013
RBCK1‐related disease: A rare multisystem disorder with polyglucosan storage, auto‐inflammation, recurrent infections, skeletal, and cardiac myopathy—Four additional patients and a review of the current literature
In this article, we report four new patients, from three kindreds, with pathogenic variants in RBCK1 and a multisystem disorder characterised by widespread polyglucosan storage. We describe the clinical presentation of progressive skeletal and cardiac myopathy, combined immunodeficiencies and auto‐inflammation, illustrate in detail the histopathological findings in multiple tissue types, and report muscle MRI findings.
- 18 March 2020
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 43 (5) , 1002-1013
RBCK1‐related disease: A rare multisystem disorder with polyglucosan storage, auto‐inflammation, recurrent infections, skeletal, and cardiac myopathy—Four additional patients and a review of the current literature
In this article, we report four new patients, from three kindreds, with pathogenic variants in RBCK1 and a multisystem disorder characterised by widespread polyglucosan storage. We describe the clinical presentation of progressive skeletal and cardiac myopathy, combined immunodeficiencies and auto‐inflammation, illustrate in detail the histopathological findings in multiple tissue types, and report muscle MRI findings.
- Open Access
- 1 June 2018
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 15, 43-45
An atypical p.N215S variant of Fabry disease with end-stage renal failure
- 1 June 2018
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 15, 43-45
Open AccessAn atypical p.N215S variant of Fabry disease with end-stage renal failure